CysLT Antibodies

Santa Cruz Biotechnology delivers a wide array of CysLT monoclonal antibodies for studying cysteinyl leukotrienes, which are lipid mediators involved in various physiological and pathological processes, including inflammation and allergic responses. CysLT monoclonal antibodies support multiple research applications such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cysteinyl leukotrienes play a crucial role in the modulation of immune responses and are implicated in conditions such as asthma, allergic rhinitis, and other inflammatory diseases. Research focused on the CysLT pathway can reveal insights into the mechanisms of these conditions and explore potential therapeutic interventions. Understanding cysteinyl leukotriene signaling pathways helps advance knowledge in inflammation and immune regulation. Investigating CysLT functions contributes to developing new therapeutic strategies for inflammatory disorders. Exploring CysLT mechanisms provides valuable information about cellular responses in health and disease. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cysteinyl leukotrienes and their impact on human health.